Ameriprise’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-89,526
| Closed | -$192K | – | 3886 |
|
|
2023
Q2 | $192K | Sell |
89,526
-23,380
| -21% | -$50.3K | ﹤0.01% | 3733 |
|
|
2023
Q1 | $220K | Buy |
112,906
+34,236
| +44% | +$66.8K | ﹤0.01% | 3701 |
|
|
2022
Q4 | $302K | Buy |
78,670
+1,567
| +2% | +$6.02K | ﹤0.01% | 3580 |
|
|
2022
Q3 | $372K | Sell |
77,103
-2,873
| -4% | -$13.9K | ﹤0.01% | 3498 |
|
|
2022
Q2 | $636K | Buy |
79,976
+4,946
| +7% | +$39.3K | ﹤0.01% | 3310 |
|
|
2022
Q1 | $1.1M | Buy |
75,030
+8,678
| +13% | +$127K | ﹤0.01% | 3171 |
|
|
2021
Q4 | $1.34M | Sell |
66,352
-2,463
| -4% | -$49.7K | ﹤0.01% | 3118 |
|
|
2021
Q3 | $1.87M | Buy |
68,815
+1,781
| +3% | +$48.4K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $1.64M | Buy |
67,034
+5,615
| +9% | +$137K | ﹤0.01% | 3004 |
|
|
2021
Q1 | $1.5M | Sell |
61,419
-12,683
| -17% | -$310K | ﹤0.01% | 2961 |
|
|
2020
Q4 | $2.37M | Buy |
74,102
+18,177
| +33% | +$582K | ﹤0.01% | 2700 |
|
|
2020
Q3 | $1.85M | Sell |
55,925
-8,785
| -14% | -$290K | ﹤0.01% | 2709 |
|
|
2020
Q2 | $3.03M | Buy |
+64,710
| New | +$3.03M | ﹤0.01% | 2393 |
|